gvtcx

UK SBS Seahorse XFe96 Analyser

UK SHARED BUSINESS SERVICES LIMITED Published 8 May 2017 Contracts Finder

key details

Value£148,907
Statuscomplete
Category (CPV) 38434000
Deadline3 May 2017
Contract start4 May 2017
Contract end3 Jun 2022
Procedurelimited
SME suitableNo
OCIDocds-b5fd17-347d2fa0-90ec-4565-88b1-959e2618f7a2

Award

SupplierValueDateStatus
AGILENT TECHNOLOGIES LDA UK LTD £148,907 2 May 2017 active

description

There is no other instrument on the market or in development that can analyse cellular metabolism at this high level. We were one of the pioneer research groups to adopt this technology and published several papers in high impact journals, which could not have been produced without the Seahorse Technology.

The Seahorse XFE is now an essential tool in cancer metabolism studies and mitochondrial toxicity research worldwide. Both these areas are priority research projects within the MRC Toxicology Unit strategic plan.

notice history

1 notice published against this procurement.

PublishedTypeRegimeNotice
8 May 2017 Award (award) · f0275225-d3a7-46f3-9d74-6b74abd1e707-145881

more from UK SHARED BUSINESS SERVICES LIMITED

all contracts from this buyer →

similar contracts awarded

Other awarded contracts in the same category. Useful for seeing who normally wins this kind of work, and at what value.

source

Published on Contracts Finder. Contact details for named individuals are not reproduced on this site.